首页> 外文期刊>Journal of Food Science Research >Nutraceuticals 2020 Preparation and Evaluation of a Novel instant Drug Delivery System (iDDS) for Nutraceutical and Pharmaceutical Active Ingredients
【24h】

Nutraceuticals 2020 Preparation and Evaluation of a Novel instant Drug Delivery System (iDDS) for Nutraceutical and Pharmaceutical Active Ingredients

机译:Nutraceuticals 2020用于营养保健品和药物活性成分的新型瞬发药物递送系统(IDDS)的制备和评估

获取原文
       

摘要

The present work is related to the development and evaluation of a novel instant drug delivery system for the Active Ingredients that are used commonly in the nutraceutical and pharmaceutical preparations. This technology can be utilized for the availability of these active ingredients in-vivo much faster than the traditional particulate drug delivery systems. The preparation of these formulations involves the development of an innovative process for the conversion of active ingredient in a molecular form/nano dispersion in a suitable matrix which can be either presented in a final dosage form of tablets, capsules, dry syrups, suspensions etc. This novel active drug matrix has been named as a??iAgglomeratesa??. The present delivery system ie iAgglomerates matrix can be used for diversified range of active ingredients which can help in significant clinical outcome of a nutraceutical or pharmaceutical product. Traditional nutraceuticals and cosmeceuticals hold pragmatic nature with respect to their definitions, claims, purposes and marketing strategies. Their definitions are not well established worldwide. They also have different regulatory definitions and registration regulatory processes in different parts of the world. Global prevalence of nutraceuticals and cosmeceuticals is noticeably high with large market share with minimal regulation compared to traditional drugs. The global market is flooded with nutraceuticals and cosmeceuticals claiming to be of natural origin and sold with a therapeutic claim by major online retail stores such as Amazon and eBay. Apart from the traditional formulations, many manufacturers and researchers use novel formulation technologies in nutraceutical and cosmeceutical formulations for different reasons and objectives. Manufacturers tend to differentiate their products with novel formulations to increase market appeal and sales. On the other hand, researchers use novel strategies to enhance nutraceuticals and cosmeceuticals activity and safety.
机译:本作本作与新型即时药物递送系统的开发和评价有关,用于营养制品和药物制剂中通常使用的活性成分。该技术可用于这些活性成分的可用性比传统的颗粒药物递送系统更快地更快。这些制剂的制备涉及在合适的基质中以分子形式/纳米分散体转化活性成分的创新方法,其可以以片剂,胶囊,干糖浆,悬浮液等的最终剂型呈现。这种新型活性药物基质被命名为a ?? iagglomeratesa。本递送系统IE IAGGLOMERATES基质可用于多样化的活性成分范围,这有助于有助于营养保健品或药物产品的显着临床结果。传统的营养包裹和化妆品统一性质对其定义,索赔,目的和营销策略具有务实的性质。他们的定义在全球范围内并不是很好。他们还在世界不同地区具有不同的监管定义和注册监管流程。与传统药物相比,全球营养保健品和化妆品的患病率明显高,市场份额最小的规定。全球市场充斥着营养保健品和药物,声称是自然来源的,并通过亚马逊和eBay等主要在线零售店进行治疗索赔。除了传统的配方之外,许多制造商和研究人员在营养不良和化妆品配方中使用了新颖的配方技术,不同的原因和目标。制造商倾向于将其产品与新颖的配方进行区分,以提高市场上诉和销售。另一方面,研究人员使用新颖的策略来增强营养保健和化妆品的活动和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号